Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	protein kinase activity	CDK20 ABL1 ABL2 ROR2 RIPK2 RIPK4 PDPK2P PAK6 LMTK3 PTK2B BMPR2 MAST1 FGFR4 PSKH2 AURKB	1.94e-05	600	139	15	GO:0004672
GeneOntologyMolecularFunction	phosphotransferase activity, alcohol group as acceptor	CDK20 ABL1 ABL2 ROR2 RIPK2 RIPK4 PDPK2P PAK6 LMTK3 PTK2B BMPR2 MAST1 FGFR4 COASY PSKH2 AURKB	3.51e-05	709	139	16	GO:0016773
GeneOntologyMolecularFunction	kinase activity	CDK20 ABL1 ABL2 ROR2 RIPK2 RIPK4 PDPK2P PAK6 LMTK3 PTK2B BMPR2 MAST1 FGFR4 COASY PSKH2 AURKB	8.50e-05	764	139	16	GO:0016301
GeneOntologyMolecularFunction	transferase activity, transferring phosphorus-containing groups	CDK20 ABL1 ABL2 ROR2 RIPK2 RIPK4 PDPK2P PAK6 LMTK3 PTK2B BMPR2 RPAP1 MAST1 FGFR4 COASY PSKH2 AURKB	2.85e-04	938	139	17	GO:0016772
GeneOntologyMolecularFunction	non-membrane spanning protein tyrosine kinase activity	ABL1 ABL2 RIPK2 PTK2B	2.92e-04	46	139	4	GO:0004715
GeneOntologyMolecularFunction	protein serine/threonine kinase activity	CDK20 RIPK2 RIPK4 PDPK2P PAK6 LMTK3 PTK2B BMPR2 MAST1 PSKH2 AURKB	2.94e-04	446	139	11	GO:0004674
GeneOntologyMolecularFunction	osmolarity-sensing monoatomic cation channel activity	TMEM63C TMEM63A	4.75e-04	5	139	2	GO:1990760
GeneOntologyMolecularFunction	protein tyrosine kinase activity	ABL1 ABL2 ROR2 RIPK2 PTK2B FGFR4	5.38e-04	145	139	6	GO:0004713
GeneOntologyMolecularFunction	peptidase activity	NAPSA CAPN14 OVCH2 ADAM21 HM13 PRSS36 USP31 YOD1 SPPL2A LTA4H PRSS48 CFAP44 ATG4D	6.59e-04	654	139	13	GO:0008233
GeneOntologyMolecularFunction	bile acid:sodium symporter activity	SLC10A3 SLC10A6	7.09e-04	6	139	2	GO:0008508
GeneOntologyMolecularFunction	osmosensor activity	TMEM63C TMEM63A	7.09e-04	6	139	2	GO:0005034
GeneOntologyMolecularFunction	inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity	INPP5B OCRL	9.87e-04	7	139	2	GO:0052659
GeneOntologyMolecularFunction	transmembrane signaling receptor activity	NPY6R ROR2 OR4E2 OR4Q3 TMEM63C GRIK1 OR2B6 OR11H6 OR10D4P TLR10 GPR146 PTK2B BMPR2 CSF3R P2RY2 SORCS2 PLXNA4 FGFR4 PLXNA2 TMEM63A	1.11e-03	1353	139	20	GO:0004888
GeneOntologyMolecularFunction	inositol-polyphosphate 5-phosphatase activity	INPP5B OCRL	1.31e-03	8	139	2	GO:0004445
GeneOntologyMolecularFunction	aspartic endopeptidase activity, intramembrane cleaving	HM13 SPPL2A	1.31e-03	8	139	2	GO:0042500
GeneOntologyMolecularFunction	inositol-1,4,5-trisphosphate 5-phosphatase activity	INPP5B OCRL	1.31e-03	8	139	2	GO:0052658
GeneOntologyMolecularFunction	phospholipase binding	PDPK2P ARHGAP6 DLC1	1.41e-03	32	139	3	GO:0043274
GeneOntologyMolecularFunction	inositol tetrakisphosphate phosphatase activity	INPP5B OCRL	1.68e-03	9	139	2	GO:0052743
GeneOntologyBiologicalProcess	positive regulation of protein binding	ABL1 ABL2 RIPK2 STING1 LFNG MAVS CTHRC1	1.65e-06	85	138	7	GO:0032092
GeneOntologyBiologicalProcess	chordate embryonic development	CDK20 ABL1 ABL2 INPP5B ROR2 E2F7 G2E3 OCRL HM13 DSCAML1 LFNG BMPR2 DLC1 CTHRC1 CNOT1 NIPBL PLXNA2 NLRP5	3.52e-05	906	138	18	GO:0043009
GeneOntologyBiologicalProcess	focal adhesion assembly	ABL1 CLASP1 PDPK2P PTK2B ARHGAP6 DLC1	4.82e-05	97	138	6	GO:0048041
GeneOntologyBiologicalProcess	embryo development ending in birth or egg hatching	CDK20 ABL1 ABL2 INPP5B ROR2 E2F7 G2E3 OCRL HM13 DSCAML1 LFNG BMPR2 DLC1 CTHRC1 CNOT1 NIPBL PLXNA2 NLRP5	4.88e-05	929	138	18	GO:0009792
GeneOntologyCellularComponent	early endosome membrane	INPP5B STEAP4 OCRL PLA2G4B CLN3 SORCS2 DOP1B TMEM63A	8.86e-05	212	139	8	GO:0031901
Domain	DMAP_binding	DIP2B DIP2A DIP2C	3.74e-06	5	136	3	PF06464
Domain	PROTEIN_KINASE_ATP	CDK20 ABL1 ABL2 ROR2 RIPK2 RIPK4 PAK6 LMTK3 PTK2B BMPR2 MAST1 FGFR4 PSKH2 AURKB	6.65e-06	459	136	14	PS00107
Domain	DMAP1-bd	DIP2B DIP2A DIP2C	7.43e-06	6	136	3	IPR010506
Domain	DMAP_binding	DIP2B DIP2A DIP2C	7.43e-06	6	136	3	SM01137
Domain	PROTEIN_KINASE_DOM	CDK20 ABL1 ABL2 ROR2 RIPK2 RIPK4 PAK6 LMTK3 PTK2B BMPR2 MAST1 FGFR4 PSKH2 AURKB	1.49e-05	493	136	14	PS50011
Domain	Rho_GTPase_activation_prot	INPP5B OCRL ARHGAP6 DLC1 PLXNA4 PLXNA2	4.43e-05	88	136	6	IPR008936
Domain	F_actin_bind	ABL1 ABL2	5.26e-05	2	136	2	PF08919
Domain	F-actin_binding	ABL1 ABL2	5.26e-05	2	136	2	IPR015015
Domain	FABD	ABL1 ABL2	5.26e-05	2	136	2	SM00808
Domain	Prot_kinase_dom	CDK20 ABL1 ABL2 ROR2 RIPK2 RIPK4 PAK6 PTK2B BMPR2 MAST1 FGFR4 PSKH2 AURKB	5.99e-05	489	136	13	IPR000719
Domain	PROTEIN_KINASE_TYR	ABL1 ABL2 ROR2 LMTK3 PTK2B FGFR4	7.66e-05	97	136	6	PS00109
Domain	RSN1_7TM	TMEM63C TMEM63A	1.57e-04	3	136	2	IPR003864
Domain	PHM7_cyt	TMEM63C TMEM63A	1.57e-04	3	136	2	IPR027815
Domain	RSN1_TM	TMEM63C TMEM63A	1.57e-04	3	136	2	PF13967
Domain	PHM7_cyt	TMEM63C TMEM63A	1.57e-04	3	136	2	PF14703
Domain	RSN1_7TM	TMEM63C TMEM63A	1.57e-04	3	136	2	PF02714
Domain	Csc1_N	TMEM63C TMEM63A	1.57e-04	3	136	2	IPR032880
Domain	HEAT_REPEAT	CLASP1 TNPO2 HEATR5A UTP20 NIPBL	1.57e-04	70	136	5	PS50077
Domain	Kinase-like_dom	CDK20 ABL1 ABL2 ROR2 RIPK2 RIPK4 PAK6 PTK2B BMPR2 MAST1 FGFR4 PSKH2 AURKB	1.67e-04	542	136	13	IPR011009
Domain	-	CLASP1 TNPO2 RTTN HEATR5A TRIP12 RIF1 UTP20 NIPBL	2.25e-04	222	136	8	1.25.10.10
Domain	Bilac:Na_transpt	SLC10A3 SLC10A6	3.13e-04	4	136	2	IPR004710
Domain	Pkinase_Tyr	ABL1 ABL2 ROR2 RIPK2 PTK2B FGFR4	3.65e-04	129	136	6	PF07714
Domain	Tyr_kinase_cat_dom	ABL1 ABL2 ROR2 PTK2B FGFR4	4.59e-04	88	136	5	IPR020635
Domain	TyrKc	ABL1 ABL2 ROR2 PTK2B FGFR4	4.59e-04	88	136	5	SM00219
Domain	Peptidase_A22B_SPP	HM13 SPPL2A	5.19e-04	5	136	2	IPR007369
Domain	Peptidase_A22B	HM13 SPPL2A	5.19e-04	5	136	2	PF04258
Domain	Ser-Thr/Tyr_kinase_cat_dom	ABL1 ABL2 ROR2 RIPK2 PTK2B FGFR4	5.22e-04	138	136	6	IPR001245
Domain	Tyr_kinase_AS	ABL1 ABL2 ROR2 PTK2B FGFR4	7.17e-04	97	136	5	IPR008266
Domain	ARM-like	CLASP1 TNPO2 RTTN HEATR5A TRIP12 RIF1 UTP20 NIPBL	8.22e-04	270	136	8	IPR011989
Domain	HEAT	CLASP1 TNPO2 UTP20 NIPBL	8.42e-04	58	136	4	IPR000357
Domain	ARM-type_fold	CLASP1 TNPO2 RTTN HEATR5A TRIP12 RIF1 UTP20 LTA4H NIPBL	8.55e-04	339	136	9	IPR016024
Domain	PSN	HM13 SPPL2A	1.08e-03	7	136	2	SM00730
Domain	SBF	SLC10A3 SLC10A6	1.08e-03	7	136	2	PF01758
Domain	BilAc:Na_symport/Acr3	SLC10A3 SLC10A6	1.08e-03	7	136	2	IPR002657
Domain	Preselin/SPP	HM13 SPPL2A	1.08e-03	7	136	2	IPR006639
Domain	RhoGAP	INPP5B OCRL ARHGAP6 DLC1	1.08e-03	62	136	4	SM00324
Domain	RhoGAP	INPP5B OCRL ARHGAP6 DLC1	1.15e-03	63	136	4	PF00620
Domain	RhoGAP_dom	INPP5B OCRL ARHGAP6 DLC1	1.22e-03	64	136	4	IPR000198
Domain	RHOGAP	INPP5B OCRL ARHGAP6 DLC1	1.22e-03	64	136	4	PS50238
Domain	-	INPP5B OCRL ARHGAP6 DLC1	1.22e-03	64	136	4	1.10.555.10
Domain	AMP-binding	DIP2B DIP2A DIP2C	1.33e-03	30	136	3	PF00501
Domain	AMP-dep_Synth/Lig	DIP2B DIP2A DIP2C	1.33e-03	30	136	3	IPR000873
Domain	Plexin_repeat	ATRNL1 PLXNA4 PLXNA2	1.60e-03	32	136	3	IPR002165
Domain	PSI	ATRNL1 PLXNA4 PLXNA2	1.60e-03	32	136	3	PF01437
Domain	Plexin_cytopl	PLXNA4 PLXNA2	1.83e-03	9	136	2	PF08337
Domain	Plexin_cytoplasmic_RasGAP_dom	PLXNA4 PLXNA2	1.83e-03	9	136	2	IPR013548
Domain	Plexin	PLXNA4 PLXNA2	1.83e-03	9	136	2	IPR031148
Domain	Protein_kinase_ATP_BS	CDK20 ABL1 ABL2 PAK6 PTK2B BMPR2 FGFR4 PSKH2 AURKB	1.85e-03	379	136	9	IPR017441
Domain	IPPc	INPP5B OCRL	2.28e-03	10	136	2	IPR000300
Domain	IPPc	INPP5B OCRL	2.28e-03	10	136	2	SM00128
Domain	PSI	ATRNL1 PLXNA4 PLXNA2	4.02e-03	44	136	3	IPR016201
Domain	PSI	ATRNL1 PLXNA4 PLXNA2	4.56e-03	46	136	3	SM00423
Domain	Ser/Thr_kinase_AS	CDK20 RIPK2 RIPK4 PAK6 BMPR2 MAST1 PSKH2 AURKB	4.67e-03	357	136	8	IPR008271
Domain	PROTEIN_KINASE_ST	CDK20 RIPK2 RIPK4 PAK6 BMPR2 MAST1 PSKH2 AURKB	5.07e-03	362	136	8	PS00108
Domain	HEAT	CLASP1 TNPO2 UTP20	5.14e-03	48	136	3	PF02985
Domain	Acyl_Trfase/lysoPLipase	PNPLA5 PLA2G4B	6.66e-03	17	136	2	IPR016035
Domain	CUB	OVCH2 CDCP1 ATRNL1	6.78e-03	53	136	3	PS01180
Domain	Pkinase	CDK20 RIPK2 RIPK4 PAK6 BMPR2 MAST1 PSKH2 AURKB	6.83e-03	381	136	8	PF00069
Pathway	REACTOME_ROLE_OF_ABL_IN_ROBO_SLIT_SIGNALING	ABL1 ABL2 CLASP1	2.45e-05	8	109	3	M27351
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	ACACA TNPO2 BCORL1 TRIP12 DSCAML1 GMPS YOD1 DIP2A RNF123 RPAP1 DUSP16 PLXNA4 UTP20 LTA4H CFAP44 CNOT1 DOP1B	9.81e-09	736	142	17	29676528
Pubmed	CGG-repeat expansion in the DIP2B gene is associated with the fragile site FRA12A on chromosome 12q13.1.	DIP2B DIP2A DIP2C	6.66e-08	3	142	3	17236128
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	DIP2B ABL1 ABL2 ACACA CLASP1 ROR2 RIPK2 PAK6 TRIP12 DENND4C USP31 PTK2B BMPR2 DLC1 DOP1B	2.64e-06	861	142	15	36931259
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	DIP2B ACACA STXBP5L ROR2 TMC6 TMEM63C G2E3 GRIK1 MSH5 HM13 GMPS EVA1C ARHGAP6 BMPR2 PVR DIP2C MAST1 SPIDR CNOT1 TMEM63A	2.90e-06	1489	142	20	28611215
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	ABL1 ACACA RTTN TMC6 RAPGEF1 SIAH2 SLC10A3 ARHGEF11 GBA2 DIP2A RPAP1 SLC45A3 PLA2G4B CLN3 DUSP16 DIP2C PREX1	2.93e-06	1105	142	17	35748872
Pubmed	Insights into the Role of Innate Immunity in Cervicovaginal Papillomavirus Infection from Studies Using Gene-Deficient Mice.	RIPK2 STING1 MAVS	1.07e-05	11	142	3	32295905
Pubmed	Integrin-mediated dendrite branch maintenance requires Abelson (Abl) family kinases.	ABL1 ABL2	1.66e-05	2	142	2	15987940
Pubmed	Cloning, genomic organization and expression pattern of a novel Drosophila gene, the disco-interacting protein 2 (dip2), and its murine homolog.	DIP2A DIP2C	1.66e-05	2	142	2	12137943
Pubmed	The Abl and Arg kinases mediate distinct modes of phagocytosis and are required for maximal Leishmania infection.	ABL1 ABL2	1.66e-05	2	142	2	22665498
Pubmed	The expression of the non-receptor tyrosine kinases Arg and c-abl is differently modulated in B lymphoid cells at different stages of differentiation.	ABL1 ABL2	1.66e-05	2	142	2	12220663
Pubmed	The Otubain YOD1 Suppresses Aggregation and Activation of the Signaling Adaptor MAVS through Lys63-Linked Deubiquitination.	YOD1 MAVS	1.66e-05	2	142	2	30952814
Pubmed	Inhibition of cell migration by Abl family tyrosine kinases through uncoupling of Crk-CAS complexes.	ABL1 ABL2	1.66e-05	2	142	2	11279004
Pubmed	Abl tyrosine kinase promotes dorsal ruffles but restrains lamellipodia extension during cell spreading on fibronectin.	ABL1 ABL2	1.66e-05	2	142	2	17686996
Pubmed	ABL tyrosine kinases: evolution of function, regulation, and specificity.	ABL1 ABL2	1.66e-05	2	142	2	20841568
Pubmed	X-inactivation analysis of embryonic lethality in Ocrl wt/-; Inpp5b-/- mice.	INPP5B OCRL	1.66e-05	2	142	2	20195868
Pubmed	Cytosolic nucleic acid sensors of the innate immune system promote liver regeneration after partial hepatectomy.	STING1 MAVS	1.66e-05	2	142	2	30115978
Pubmed	Human cytomegalovirus-encoded US9 targets MAVS and STING signaling to evade type I interferon immune responses.	STING1 MAVS	1.66e-05	2	142	2	29317664
Pubmed	The GRA15 protein from Toxoplasma gondii enhances host defense responses by activating the interferon stimulator STING.	STING1 MAVS	1.66e-05	2	142	2	31416833
Pubmed	Antiviral Adaptor MAVS Promotes Murine Lupus With a B Cell Autonomous Role.	STING1 MAVS	1.66e-05	2	142	2	31681326
Pubmed	Disrupted sperm function and fertilin beta processing in mice deficient in the inositol polyphosphate 5-phosphatase Inpp5b.	INPP5B OCRL	1.66e-05	2	142	2	11784089
Pubmed	Abl family tyrosine kinases regulate sialylated ganglioside receptors for polyomavirus.	ABL1 ABL2	1.66e-05	2	142	2	20181697
Pubmed	[Effect of gemcitabine on granulocyte colony-stimulating factor receptor and bcr/abl mRNA in patients with chronic myeloid leukemia].	ABL1 CSF3R	1.66e-05	2	142	2	21129254
Pubmed	F-actin-binding domain of c-Abl regulates localized phosphorylation of C3G: role of C3G in c-Abl-mediated cell death.	ABL1 RAPGEF1	1.66e-05	2	142	2	20581864
Pubmed	Functional overlap between murine Inpp5b and Ocrl1 may explain why deficiency of the murine ortholog for OCRL1 does not cause Lowe syndrome in mice.	INPP5B OCRL	1.66e-05	2	142	2	9593760
Pubmed	c-Abl and Arg tyrosine kinases regulate lysosomal degradation of the oncoprotein Galectin-3.	ABL1 ABL2	1.66e-05	2	142	2	20150913
Pubmed	c-Abl tyrosine kinase interacts with MAVS and regulates innate immune response.	ABL1 MAVS	1.66e-05	2	142	2	19914245
Pubmed	Beneficial bacteria activate type-I interferon production via the intracellular cytosolic sensors STING and MAVS.	STING1 MAVS	1.66e-05	2	142	2	31941397
Pubmed	Global Regulation of Differential Gene Expression by c-Abl/Arg Oncogenic Kinases.	ABL1 ABL2	1.66e-05	2	142	2	28555614
Pubmed	OCRL-mutated fibroblasts from patients with Dent-2 disease exhibit INPP5B-independent phenotypic variability relatively to Lowe syndrome cells.	INPP5B OCRL	1.66e-05	2	142	2	25305077
Pubmed	Loss of dendrite stabilization by the Abl-related gene (Arg) kinase regulates behavioral flexibility and sensitivity to cocaine.	ABL1 ABL2	1.66e-05	2	142	2	19805386
Pubmed	Kidney Tubular Ablation of Ocrl/Inpp5b Phenocopies Lowe Syndrome Tubulopathy.	INPP5B OCRL	1.66e-05	2	142	2	27895154
Pubmed	c-Abl and Arg are activated in human primary melanomas, promote melanoma cell invasion via distinct pathways, and drive metastatic progression.	ABL1 ABL2	1.66e-05	2	142	2	21892207
Pubmed	Mouse model for Lowe syndrome/Dent Disease 2 renal tubulopathy.	INPP5B OCRL	1.66e-05	2	142	2	21183592
Pubmed	Combating acquired resistance to MAPK inhibitors in melanoma by targeting Abl1/2-mediated reactivation of MEK/ERK/MYC signaling.	ABL1 ABL2	1.66e-05	2	142	2	33122628
Pubmed	Lowe syndrome patient fibroblasts display Ocrl1-specific cell migration defects that cannot be rescued by the homologous Inpp5b phosphatase.	INPP5B OCRL	1.66e-05	2	142	2	19700499
Pubmed	Abl family nonreceptor tyrosine kinases modulate short-term synaptic plasticity.	ABL1 ABL2	1.66e-05	2	142	2	12626632
Pubmed	The Abl family kinases: mechanisms of regulation and signaling.	ABL1 ABL2	1.66e-05	2	142	2	12374288
Pubmed	Defective T cell development and function in the absence of Abelson kinases.	ABL1 ABL2	1.66e-05	2	142	2	18025176
Pubmed	Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.	G2E3 HEATR5A RPAP1 SORCS2 WDR35 PREX1	4.11e-05	153	142	6	10718198
Pubmed	Structural Basis for Plexin Activation and Regulation.	PLXNA4 PLXNA2	4.95e-05	3	142	2	27397516
Pubmed	Interactions between plexin-A2, plexin-A4, and semaphorin 6A control lamina-restricted projection of hippocampal mossy fibers.	PLXNA4 PLXNA2	4.95e-05	3	142	2	17296555
Pubmed	Co-expression of mouse TMEM63A, TMEM63B and TMEM63C confers hyperosmolarity activated ion currents in HEK293 cells.	TMEM63C TMEM63A	4.95e-05	3	142	2	27045885
Pubmed	Inhibition of cGAS-Mediated Interferon Response Facilitates Transgene Expression.	STING1 MAVS	4.95e-05	3	142	2	32283527
Pubmed	Characterization of p87C3G, a novel, truncated C3G isoform that is overexpressed in chronic myeloid leukemia and interacts with Bcr-Abl.	ABL1 RAPGEF1	4.95e-05	3	142	2	16443220
Pubmed	MutS homologue hMSH5: role in cisplatin-induced DNA damage response.	ABL1 MSH5	4.95e-05	3	142	2	22401567
Pubmed	Two distinct phosphorylation pathways have additive effects on Abl family kinase activation.	ABL1 ABL2	4.95e-05	3	142	2	12748290
Pubmed	Hepatitis C virus NS4B protein targets STING and abrogates RIG-I-mediated type I interferon-dependent innate immunity.	STING1 MAVS	4.95e-05	3	142	2	22911572
Pubmed	Abl family kinases regulate FcγR-mediated phagocytosis in murine macrophages.	ABL1 ABL2	4.95e-05	3	142	2	23100514
Pubmed	Early Transcriptional Signature in Dendritic Cells and the Induction of Protective T Cell Responses Upon Immunization With VLPs Containing TLR Ligands-A Role for CCL2.	STING1 MAVS	4.95e-05	3	142	2	31428084
Pubmed	Neuropilin-1 stimulates tumor growth by increasing fibronectin fibril assembly in the tumor microenvironment.	ABL1 ABL2	4.95e-05	3	142	2	22738912
Pubmed	Genetic variants of the MAVS, MITA and MFN2 genes are not associated with leprosy in Han Chinese from Southwest China.	STING1 MAVS	4.95e-05	3	142	2	27553710
Pubmed	ArgBP2, a multiple Src homology 3 domain-containing, Arg/Abl-interacting protein, is phosphorylated in v-Abl-transformed cells and localized in stress fibers and cardiocyte Z-disks.	ABL1 ABL2	4.95e-05	3	142	2	9211900
Pubmed	OCRL deficiency impairs endolysosomal function in a humanized mouse model for Lowe syndrome and Dent disease.	INPP5B OCRL	4.95e-05	3	142	2	30590522
Pubmed	Ubiquitination and degradation of the Arg tyrosine kinase is regulated by oxidative stress.	ABL1 ABL2	4.95e-05	3	142	2	15735735
Pubmed	Endogenous retroviruses are associated with hippocampus-based memory impairment.	STING1 MAVS	4.95e-05	3	142	2	31792184
Pubmed	Role of transmembrane semaphorin Sema6A in oligodendrocyte differentiation and myelination.	PLXNA4 PLXNA2	4.95e-05	3	142	2	22777942
Pubmed	3β-hydroxysteroid-Δ24 reductase dampens anti-viral innate immune responses by targeting K27 ubiquitination of MAVS and STING.	STING1 MAVS	4.95e-05	3	142	2	38032198
Pubmed	The E3 ubiquitin ligase MARCH1 regulates antimalaria immunity through interferon signaling and T cell activation.	STING1 MAVS	4.95e-05	3	142	2	32606244
Pubmed	Functional interaction between the c-Abl and Arg protein-tyrosine kinases in the oxidative stress response.	ABL1 ABL2	4.95e-05	3	142	2	12569093
Pubmed	Protein kinase C-associated kinase (PKK) mediates Bcl10-independent NF-kappa B activation induced by phorbol ester.	RIPK2 RIPK4	4.95e-05	3	142	2	12091384
Pubmed	Hepatitis C virus NS4B blocks the interaction of STING and TBK1 to evade host innate immunity.	STING1 MAVS	4.95e-05	3	142	2	23542348
Pubmed	Evidence for a direct involvement of hMSH5 in promoting ionizing radiation induced apoptosis.	ABL1 MSH5	4.95e-05	3	142	2	19442657
Pubmed	A PH domain within OCRL bridges clathrin-mediated membrane trafficking to phosphoinositide metabolism.	INPP5B OCRL	4.95e-05	3	142	2	19536138
Pubmed	Innate Immune Nod1/RIP2 Signaling Is Essential for Cardiac Hypertrophy but Requires Mitochondrial Antiviral Signaling Protein for Signal Transductions and Energy Balance.	RIPK2 MAVS	4.95e-05	3	142	2	33070627
Pubmed	Non-receptor tyrosine kinases c-Abl and Arg regulate the activity of C/EBPbeta.	ABL1 ABL2	4.95e-05	3	142	2	19563810
Pubmed	A novel locus for body mass index on 5p15.2: a meta-analysis of two genome-wide association studies.	MARCHF6 GRIK1	4.95e-05	3	142	2	22446040
Pubmed	Direct interaction of Jak1 and v-Abl is required for v-Abl-induced activation of STATs and proliferation.	ABL1 ABL2	4.95e-05	3	142	2	9774693
Pubmed	ShcA regulates thymocyte proliferation through specific transcription factors and a c-Abl-dependent signaling axis.	ABL1 ABL2	4.95e-05	3	142	2	25691660
Pubmed	Catalase activity is regulated by c-Abl and Arg in the oxidative stress response.	ABL1 ABL2	4.95e-05	3	142	2	12777400
Pubmed	Chemotherapy-induced transposable elements activate MDA5 to enhance haematopoietic regeneration.	STING1 MAVS	4.95e-05	3	142	2	34253898
Pubmed	Innate immune signaling drives late cardiac toxicity following DNA-damaging cancer therapies.	STING1 MAVS	4.95e-05	3	142	2	36534085
Pubmed	Repulsive and attractive semaphorins cooperate to direct the navigation of cardiac neural crest cells.	PLXNA4 PLXNA2	4.95e-05	3	142	2	18625214
Pubmed	Arg kinase regulates prefrontal dendritic spine refinement and cocaine-induced plasticity.	ABL1 ABL2	4.95e-05	3	142	2	22396406
Pubmed	The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation.	STING1 MAVS	4.95e-05	3	142	2	18818105
Pubmed	TRIM30α Is a Negative-Feedback Regulator of the Intracellular DNA and DNA Virus-Triggered Response by Targeting STING.	STING1 MAVS	4.95e-05	3	142	2	26114947
Pubmed	Structural basis for phosphoinositide substrate recognition, catalysis, and membrane interactions in human inositol polyphosphate 5-phosphatases.	INPP5B OCRL	4.95e-05	3	142	2	24704254
Pubmed	Catalase is regulated by ubiquitination and proteosomal degradation. Role of the c-Abl and Arg tyrosine kinases.	ABL1 ABL2	4.95e-05	3	142	2	12950161
Pubmed	OCRL regulates lysosome positioning and mTORC1 activity through SSX2IP-mediated microtubule anchoring.	INPP5B OCRL	4.95e-05	3	142	2	33987909
Pubmed	Physical and functional interaction between hMSH5 and c-Abl.	ABL1 MSH5	4.95e-05	3	142	2	16397227
Pubmed	Glutathione peroxidase 1 is regulated by the c-Abl and Arg tyrosine kinases.	ABL1 ABL2	4.95e-05	3	142	2	12893824
Pubmed	Influenza A virus M2 protein triggers mitochondrial DNA-mediated antiviral immune responses.	STING1 MAVS	4.95e-05	3	142	2	31604929
Pubmed	TLR sensing of bacterial spore-associated RNA triggers host immune responses with detrimental effects.	RIPK2 STING1 MAVS	6.15e-05	19	142	3	28400473
Pubmed	Prediction of the coding sequences of unidentified human genes. XIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	STXBP5L DIP2C MAST1 CNOT1 DOP1B	6.41e-05	102	142	5	10231032
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	ORC3 MPDU1 BCORL1 MUC16 HM13 DCAF12L2 RBM22 RNF123 CNOT1 PREX1 NIPBL	6.62e-05	638	142	11	31182584
Pubmed	Interferon inducible GBPs restrict Burkholderia thailandensis motility induced cell-cell fusion.	RIPK2 STING1 MAVS	7.22e-05	20	142	3	32150572
Pubmed	Localization and phosphorylation of Abl-interactor proteins, Abi-1 and Abi-2, in the developing nervous system.	ABL1 ABL2	9.88e-05	4	142	2	10995551
Pubmed	Arg interacts with cortactin to promote adhesion-dependent cell edge protrusion.	ABL1 ABL2	9.88e-05	4	142	2	19414610
Pubmed	Chromosome assignment of four plexin A genes (Plxna1, Plxna2, Plxna3, Plxna4) in mouse, rat, Syrian hamster and Chinese hamster.	PLXNA4 PLXNA2	9.88e-05	4	142	2	11306810
Pubmed	PlexinA polymorphisms mediate the developmental trajectory of human corpus callosum microstructure.	PLXNA4 PLXNA2	9.88e-05	4	142	2	25518740
Pubmed	Bidirectional signaling links the Abelson kinases to the platelet-derived growth factor receptor.	ABL1 ABL2	9.88e-05	4	142	2	14993293
Pubmed	SCD2-mediated monounsaturated fatty acid metabolism regulates cGAS-STING-dependent type I IFN responses in CD4+ T cells.	ACACA STING1	9.88e-05	4	142	2	34188173
Pubmed	Reciprocal regulation of Abl and receptor tyrosine kinases.	ABL1 ABL2	9.88e-05	4	142	2	19275932
Pubmed	SHP-2 is a novel target of Abl kinases during cell proliferation.	ABL1 ABL2	9.88e-05	4	142	2	18827006
Pubmed	Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling.	STING1 MAVS	9.88e-05	4	142	2	25642773
Pubmed	Identification of signal peptide peptidase, a presenilin-type aspartic protease.	HM13 SPPL2A	9.88e-05	4	142	2	12077416
Pubmed	Molecular cloning of a docking protein, BRDG1, that acts downstream of the Tec tyrosine kinase.	ABL1 PTK2B	9.88e-05	4	142	2	10518561
Pubmed	Borrelia burgdorferi Engages Mammalian Type I IFN Responses via the cGAS-STING Pathway.	STING1 MAVS	9.88e-05	4	142	2	37067290
Pubmed	Abl family kinases modulate T cell-mediated inflammation and chemokine-induced migration through the adaptor HEF1 and the GTPase Rap1.	ABL1 ABL2	9.88e-05	4	142	2	22810897
Pubmed	MARCH6 and TRC8 facilitate the quality control of cytosolic and tail-anchored proteins.	MARCHF6 HM13	9.88e-05	4	142	2	29519897
Pubmed	Association between C13ORF31, NOD2, RIPK2 and TLR10 polymorphisms and urothelial bladder cancer.	RIPK2 TLR10	9.88e-05	4	142	2	22504414
Interaction	RNF123 interactions	ACACA TNPO2 BCORL1 GRIK1 TRIP12 DSCAML1 GMPS YOD1 DIP2A RNF123 RPAP1 DUSP16 PLXNA4 UTP20 LTA4H CFAP44 CNOT1 DOP1B	9.01e-06	824	134	18	int:RNF123
Interaction	SEMA5A interactions	STING1 PLXNA4 PLXNA2	9.87e-06	7	134	3	int:SEMA5A
GeneFamily	Plexins	PLXNA4 PLXNA2	9.40e-04	9	94	2	683
GeneFamily	Receptor Tyrosine Kinases\|CD molecules	ROR2 LMTK3 FGFR4	1.17e-03	40	94	3	321
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	LRIT2 ROR2 DSCAML1 IGFBP7 FGFR4	1.53e-03	161	94	5	593
Coexpression	GSE7831_UNSTIM_VS_CPG_STIM_PDC_1H_UP	TMC6 MARCHF6 STING1 HM13 LFNG PTK2B HSD3B7 CLN3 PREX1	1.44e-06	200	141	9	M6944
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D231\|Adult / Lineage, Cell type, age group and donor	NAPSA STEAP4 AQP3 ESYT3 NTN4 DLC1 CSF3R SORCS2	1.64e-07	189	141	8	dab54a52358f66a8a9460cd6089a06c5fa7e7a5d
ToppCell	Adult\|World / Lineage, Cell type, age group and donor	NAPSA TMC6 SLC22A15 RAPGEF1 PTK2B CSF3R MFSD13A	2.43e-06	189	141	7	5cd285bfad973125d46d704fec18b21266a63379
ToppCell	droplet-Tongue-TONGUE-1m-Epithelial-filiform\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OVCH2 ROR2 PRSS36 ESYT3 P2RY2 CTHRC1 PLXNA2	2.51e-06	190	141	7	8a53f4d3c9aca45b5826f53f7dcdfb8bc8280acb
ToppCell	ASK454\|World / Donor, Lineage and Cell class of Lung cells from Dropseq	NAPSA STEAP4 AQP3 NTN4 PIGA CSF3R SLC45A3	2.69e-06	192	141	7	6b047b445a0df0ecdd6d7baf388a0d966a93b3a2
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	NAPSA STEAP4 ESYT3 NTN4 DLC1 CSF3R SORCS2	2.69e-06	192	141	7	fb2f0e897228f808d9ff734ad05e9b49dc38fa50
ToppCell	ASK428-Epithelial-Type_2\|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq	NAPSA STEAP4 AQP3 NTN4 DLC1 PIGA CSF3R	3.30e-06	198	141	7	ec0d1801363adb70c6a26655b79d12b438c7417d
ToppCell	ASK454-Immune-B_cell\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	NAPSA STEAP4 AQP3 NTN4 CSF3R IFI30 LTA4H	3.41e-06	199	141	7	b9b0ae81b9e7e35023c73d3b936e88167461ba54
ToppCell	Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	NAPSA STEAP4 AQP3 ESYT3 NTN4 PIGA CSF3R	3.53e-06	200	141	7	acc771a902cf2f060c3eb9aedb72a256f5778a6c
ToppCell	Parenchyma_COVID-19-Epithelial-TX-AT2-2\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	NAPSA STEAP4 AQP3 ESYT3 NTN4 PIGA CSF3R	3.53e-06	200	141	7	ceb613ac6cdf0e3e6bb3f04d89034e18a524cefb
ToppCell	Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	NAPSA STEAP4 AQP3 ESYT3 NTN4 PIGA CSF3R	3.53e-06	200	141	7	eb44d1f80ecaac3a022cd04ab16dc36151e45488
ToppCell	wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_3\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	MUC16 LMTK3 CDCP1 AQP3 SORCS2 ATP12A	1.95e-05	174	141	6	9e5fae9ecc7c0111fc8a252e72b89dc89c0d3a7c
ToppCell	LPS-IL1RA-Epithelial_alveolar-Mes-Like-AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NAPSA CDCP1 PRSS36 ESYT3 NTN4	2.11e-05	105	141	5	8d5528ae2bdba17e2474a7ca07fc8596d1b04647
ToppCell	390C-Epithelial_cells-Epithelial-B_(AT2)\|390C / Donor, Lineage, Cell class and subclass (all cells)	NAPSA STEAP4 AQP3 ESYT3 NTN4 CSF3R	2.29e-05	179	141	6	466da2bc3bfc534ffe111c8c28ece7a3cfa08051
ToppCell	390C-Epithelial_cells-Epithelial-B_(AT2)-\|390C / Donor, Lineage, Cell class and subclass (all cells)	NAPSA STEAP4 AQP3 ESYT3 NTN4 CSF3R	2.29e-05	179	141	6	f4bdebb77d39e63160fbf3a85a340ce4d52b7cfd
ToppCell	Control-Epithelial_cells-AT2\|Control / group, cell type (main and fine annotations)	NAPSA ACACA STEAP4 NTN4 DLC1 CSF3R	2.36e-05	180	141	6	198b19e7910b4a8cc7e820c525ab357c7f99f578
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HEATR5A RIPK4 DSCAML1 NTN4 PLA2G4B SORCS2	2.44e-05	181	141	6	b45b11428d13950369347e051d4d517efb2bd4fd
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NAPSA ACACA NTN4 DLC1 CSF3R SORCS2	2.59e-05	183	141	6	6847c1252d6bb105524f812658112517fd351eab
ToppCell	LPS-IL1RA\|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	STEAP4 RAPGEF1 USP31 EVA1C CD58 PLXNA2	2.67e-05	184	141	6	c066c2ec4f0f1d6eb183fca5c7bb0cd45c9950dc
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	STXBP5L E2F7 AQP3 GPR146 DUSP16 AURKB	2.84e-05	186	141	6	993c58ef4445bf81bbc9b489635883848b5b4c8e
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	NAPSA ACACA STEAP4 HM13 CSF3R LTA4H	2.84e-05	186	141	6	acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ROR2 E2F7 PAK6 ATRNL1 PIF1 AURKB	2.93e-05	187	141	6	e41e39fd3791acf8ae5376cc5061e196d96868ae
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ROR2 E2F7 PAK6 ATRNL1 PIF1 AURKB	2.93e-05	187	141	6	cefa211ef224e803ea9467882e2ca74d0b1492f1
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	OVCH2 ROR2 AQP3 GREB1L SORCS2 ATP12A	3.11e-05	189	141	6	3a295c215b5c18e7c673f92b7af5be523421682c
ToppCell	COVID-19-lung-AT2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	NAPSA ACACA AQP3 ESYT3 NTN4 CSF3R	3.20e-05	190	141	6	27a1a86620fe9b5ee930d388b32352206485e6d0
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NAPSA ACACA NTN4 DLC1 CSF3R SORCS2	3.30e-05	191	141	6	a0332a4ef629510fb313ec119195c44a3f704a80
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-D\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	RIPK2 HM13 CDCP1 HSD3B7 CD58 IFI30	3.30e-05	191	141	6	a143af67fc3270439f390edec599d2e3d29a107f
ToppCell	Epithelial-alveolar_epithelial_cell_type_2\|World / Lineage, Cell type, age group and donor	NAPSA ACACA NTN4 DLC1 CSF3R SORCS2	3.39e-05	192	141	6	58c3737be7acce39fd2b91d70d6d7b2bbaa4f710
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NAPSA ACACA STEAP4 NTN4 DLC1 CSF3R	3.49e-05	193	141	6	fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2\|Adult / Lineage, Cell type, age group and donor	NAPSA ACACA NTN4 DLC1 CSF3R SORCS2	3.49e-05	193	141	6	738f4f0a9ddde2432b429ab46838e353b1790589
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NAPSA ACACA STEAP4 NTN4 DLC1 CSF3R	3.49e-05	193	141	6	f3cc7cfdbc164a4ed42f87647111522b7d393bcb
ToppCell	390C-Endothelial_cells-Endothelial-B_(Artery)\|390C / Donor, Lineage, Cell class and subclass (all cells)	GPR146 EVA1C BMPR2 PVR SLC10A6 PLXNA2	3.60e-05	194	141	6	f8a59bd4609d147d8a706bf606e9e8173c9992a3
ToppCell	390C-Endothelial_cells-Endothelial-B_(Artery)-\|390C / Donor, Lineage, Cell class and subclass (all cells)	GPR146 EVA1C BMPR2 PVR SLC10A6 PLXNA2	3.60e-05	194	141	6	04b1acc2e879feafb43f75435281c5acd8d23be2
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-D\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	GLB1L STING1 PRSS36 PLA2G4B IFI30 LTA4H	3.60e-05	194	141	6	b829a63b51b92507a53ffd0393bd9458b2b9440f
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NAPSA ACACA NTN4 DLC1 CSF3R SORCS2	3.60e-05	194	141	6	97534c8bba895a7913665e03ae4e5c4a6ad71daf
ToppCell	normal_Lung-Epithelial_cells-AT2\|Epithelial_cells / Location, Cell class and cell subclass	NAPSA STEAP4 AQP3 NTN4 DLC1 CSF3R	3.70e-05	195	141	6	81e13fe337f1d0a83d0deb86a0df797d306cd24d
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NAPSA STEAP4 ESYT3 NTN4 DLC1 PIGA	3.70e-05	195	141	6	d9694db6bf239636d1335016878c98f6ee2eb0eb
ToppCell	ASK440-Epithelial-Type_2\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	NAPSA STEAP4 ESYT3 NTN4 DLC1 CSF3R	3.81e-05	196	141	6	754b4202b617165c6994a0b5a9b1e486dccdd44d
ToppCell	LAM-Epithelial-AT2\|LAM / Condition, Lineage and Cell class	NAPSA STEAP4 AQP3 NTN4 DLC1 CSF3R	3.81e-05	196	141	6	9165041ef3d56b4d069497fee03dd1c6e273211d
ToppCell	LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_only / Treatment groups by lineage, cell group, cell type	CDK20 NAPSA PRSS36 PVR SORCS2 PLXNA2	3.92e-05	197	141	6	6b6504c47c309bac4f790e2f372d454bbdea49e8
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NAPSA STEAP4 ESYT3 DLC1 PIGA DUSP16	3.92e-05	197	141	6	bf10727fbe90b71d2ac60a11711e5f0701b3799d
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	NAPSA STEAP4 CDCP1 NTN4 ABCA5 LTA4H	4.03e-05	198	141	6	285f729140b1df029c24f6ca1d2438470ac51794
ToppCell	356C-Myeloid-Macrophage-SPP1+_Macrophage_3\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	ABL2 HM13 AQP3 HSD3B7 CLN3 LTA4H	4.03e-05	198	141	6	3b4611c9ee4d42e042a29ddb4580a95938d87d65
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NAPSA ACACA SLC22A15 NTN4 CSF3R SORCS2	4.03e-05	198	141	6	f948391296c261c473d339069a6d0f20ccd6f38f
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NAPSA ACACA SLC22A15 NTN4 CSF3R SORCS2	4.03e-05	198	141	6	2e2a4e1756bba6f4fbe529559a97d2993c890b4b
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NAPSA ACACA ESYT3 NTN4 DLC1 CSF3R	4.14e-05	199	141	6	8587bd98de7767a575088afbea07a1feb4516b9b
ToppCell	Parenchymal-10x3prime_v2-Epithelial-Epi_airway_basal\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	UGT1A6 RIPK4 AQP3 GREB1L ATP12A ALDH3A2	4.14e-05	199	141	6	995d710d7302272e7951a5a5d766d1039089ee2b
ToppCell	ASK454-Immune-B_cell\|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq	NAPSA STEAP4 AQP3 NTN4 CSF3R IFI30	4.14e-05	199	141	6	cbfabf8e895abe454606b990f99e3738f4263ffe
ToppCell	5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NAPSA STEAP4 ESYT3 NTN4 DLC1 CSF3R	4.14e-05	199	141	6	2dc33804f6691d7c9682e6c9b885e945fb97fc36
ToppCell	LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	NAPSA NTN4 ABCA5 PLA2G4B LTA4H PLXNA2	4.26e-05	200	141	6	e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae
ToppCell	mLN-Dendritic_cell-cDC2\|Dendritic_cell / Region, Cell class and subclass	RIPK2 LFNG CSF3R P2RY2 CLN3 IFI30	4.26e-05	200	141	6	e3f7852aaa26a9b3e626d85e40afde799e873045
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ABL2 RIPK2 RAPGEF1 CDCP1 PTK2B IFI30	4.26e-05	200	141	6	851c57187db8bc91a393655bca5f13e787a723d4
ToppCell	PCW_05-06-Epithelial-Epithelial_ciliated-epi_ciliated_(14)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	RIPK4 PAK6 OR2B6 CFAP44 SPOCD1	8.36e-05	140	141	5	8abbd5dc799943b49cd0045d0da405c3f3d0db6b
ToppCell	PCW_05-06-Epithelial-Epithelial_ciliated\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	RIPK4 PAK6 OR2B6 CFAP44 SPOCD1	8.36e-05	140	141	5	e4689232c473d239b07a7fbcaaa3414fbd9badea
ToppCell	LPS-antiTNF-Endothelial-Epi-like\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RIPK4 PAK6 NTN4 UTP20 CFAP44	9.55e-05	144	141	5	75b16adfbe84f69376e6566d531ba7919d5c5192
ToppCell	343B-Myeloid-Macrophage-SPP1+_Macrophage_3\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	ABL2 BCORL1 TRIP12 MAVS NDUFV1-DT	9.55e-05	144	141	5	5e948d4cb913ccd8f82262a1b4d20967aadab3ab
ToppCell	LPS-antiTNF-Endothelial-Epi-like-Gen_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ACACA RIPK4 DSCAML1 UTP20 CFAP44	1.16e-04	150	141	5	9cb3332924bd67c966873343c14445e30d3f384f
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	AQP3 ARHGAP6 SORCS2 DIP2C NDUFV1-DT	1.19e-04	151	141	5	f4f7156b2c0cfc78fd1841e07c9915d97ced561f
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	OVCH2 G2E3 RIPK4 LMTK3 DCAF12L2	1.35e-04	155	141	5	8b524c65fa5c901f70c7caae4ec7fd2859eaf227
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_low-phase\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	OVCH2 G2E3 RIPK4 LMTK3 DCAF12L2	1.35e-04	155	141	5	7fe8b8c0c8a9e3190cfd52d3934509e6780e1717
ToppCell	droplet-Liver-Hepatocytes-24m-Myeloid-macrophage/monocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA G2E3 STING1 ZFC3H1 LFNG	1.43e-04	157	141	5	d8e283414a770f05d71f0455d0822e9a9660b115
ToppCell	droplet-Liver-Hepatocytes-24m-Myeloid-myeloid_leukocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA G2E3 STING1 ZFC3H1 LFNG	1.43e-04	157	141	5	165e98bf944572cafbc06ef43c9eab7bd6bea1c2
ToppCell	facs-Lung-Endomucin-24m-Myeloid\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA PTK2B CSF3R DUSP16 IFI30	1.52e-04	159	141	5	886cbaef39a3517514a3896b6b960d01a3af043d
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	UGT1A6 TMEM63C NTN4 DHRS7 FGFR4	1.66e-04	162	141	5	f0a92c92c3a6cf9fa11fb279a584e7f328cb7d43
ToppCell	mild-Myeloid-Eosinophils\|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	INPP5B HEATR5A LFNG HSD3B7 SLC45A3	1.71e-04	163	141	5	7c57d541a88e9afa079e95b8a6ecdea60a0c6aaa
ToppCell	343B-Lymphocytic-NK_cells-NK_cell_B0\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	ABL1 AQP3 ARHGAP6 DUSP16 MAST1	2.02e-04	169	141	5	89b5452e0d8d058648a1d2659f1611fd6aebc6b6
ToppCell	facs-Lung-nan-3m-Endothelial-Vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	G2E3 PTK2B BMPR2 SPIDR PLXNA2	2.07e-04	170	141	5	8e1f757ed62218c0fb6525f49d142dd2cd29acf9
ToppCell	facs-Lung-nan-3m-Endothelial-vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	G2E3 PTK2B BMPR2 SPIDR PLXNA2	2.07e-04	170	141	5	67d7e1da3ebd2d14cb2e67799e94d655027ed5c4
ToppCell	3'_v3-GI_small-bowel-Mast-Mast_cell_granulo-myelo\|GI_small-bowel / Manually curated celltypes from each tissue	ARHGAP6 HSD3B7 DLC1 SLC45A3 MAST1	2.19e-04	172	141	5	3df11aefc09762fd1f94441324551178e030b249
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Monocyte-derived_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MUC16 RAPGEF1 CSF3R PREX1 NLRP5	2.19e-04	172	141	5	72fbfa890995e47048b47199c170cc7dcd7661f8
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MUC16 RAPGEF1 CSF3R PREX1 NLRP5	2.19e-04	172	141	5	2ca6f0d1181aabe0d0e3e8f2e193f08dbda42dea
ToppCell	3'_v3-bone_marrow-Lymphocytic_B-GC_B_(I)\|bone_marrow / Manually curated celltypes from each tissue	RTTN E2F7 TLR10 YOD1 AURKB	2.25e-04	173	141	5	67f0f0bf88eab69987b71d96b864ed2b14975adb
ToppCell	facs-Diaphragm-Limb_Muscle-18m-Lymphocytic-B_cell\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA PTK2B ESYT3 IFI30 AURKB	2.25e-04	173	141	5	a693772987f1baee533dd0bd285a3c7b5619a73b
ToppCell	tumor_Lymph_Node_/_Brain-B_lymphocytes-Undetermined\|B_lymphocytes / Location, Cell class and cell subclass	RIPK4 GBA2 PRSS36 EVA1C ABCA5	2.31e-04	174	141	5	390bd41ef114464f3db3e0cac4e67fe7571b4c23
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ACACA TMEM63C MUC16 AQP3 AURKB	2.31e-04	174	141	5	207aa0118633cbe9a65839bbb1bb3ba9f8118ad2
ToppCell	pdx-Tumor_cells-T2\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	ABL2 DSCAML1 EVA1C DLC1 ABCA5	2.43e-04	176	141	5	1e21f80cf0e695ffdd63e4a72cf1e3fa41b60341
ToppCell	wk_15-18-Epithelial-Proximal_epithelial-Proximal_secretory_3\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	MUC16 STEAP4 AQP3 ATP12A NDUFV1-DT	2.43e-04	176	141	5	8d9d0fb46c418b2067be58aec822e8c2b1561461
ToppCell	LPS-antiTNF-Myeloid-Neutrophils-Neutrophils\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	STEAP4 LFNG PTK2B CSF3R IFI30	2.57e-04	178	141	5	afcc92e8fe313c85eaf617cf4dbc3058da6c99d6
ToppCell	LPS-antiTNF-Myeloid-Neutrophils\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	STEAP4 LFNG PTK2B CSF3R IFI30	2.57e-04	178	141	5	bd689205bc92cda5f71df64c2332ff76adcd84b4
ToppCell	PCW_10-12-Endothelial-Endothelial_mature-lymphatic\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	CYP8B1 GPR146 USP31 SLC45A3 CTHRC1	2.63e-04	179	141	5	ab3d08b51cd7a37582305615ee221c7a2af83b40
ToppCell	PCW_10-12-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	CYP8B1 GPR146 USP31 SLC45A3 CTHRC1	2.63e-04	179	141	5	35fe9961e228ce255e3317fc244efa35b5adbf8b
ToppCell	3'-Pediatric_IBD-SmallIntestine-Hematopoietic-B_cells-FCRL4+_Memory_B\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MUC16 TLR10 IGHE IFI30 PREX1	2.70e-04	180	141	5	eedb6d89680f968167afb1dcd132c9de9096b50f
ToppCell	wk_15-18-Epithelial-Proximal_epithelial-basal_late\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	UGT1A6 RIPK4 AQP3 GREB1L EVA1C	2.70e-04	180	141	5	255097d8eb244a32eb2ecd0e7e48e1a20bafb5cd
ToppCell	droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	INPP5B LMTK3 DLC1 IGFBP7 ATRNL1	2.77e-04	181	141	5	4df7972f88117108698efd06b124b232f8588981
ToppCell	RA-07._Pericyte\|RA / Chamber and Cluster_Paper	STEAP4 DSCAML1 ARHGAP6 DLC1 IGFBP7	2.77e-04	181	141	5	8dfb42d096db6c2df9b41303a7199d134d4bff07
ToppCell	TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-2\|TCGA-Skin / Sample_Type by Project: Shred V9	ABL2 HEATR5A USP31 BMPR2 DIP2C	2.77e-04	181	141	5	9d5b331cabc5524f0a9fd8b571e87be4c447c7d4
ToppCell	droplet-Liver-hepatocytes-3m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	INPP5B LMTK3 DLC1 IGFBP7 ATRNL1	2.77e-04	181	141	5	cbb530566893281289026bfd93adf721decd4ca3
ToppCell	RA-07._Pericyte\|World / Chamber and Cluster_Paper	STEAP4 DSCAML1 ARHGAP6 DLC1 IGFBP7	2.84e-04	182	141	5	2075efeae633550fb2eb026d0dfd741c8252482e
ToppCell	LPS-IL1RA+antiTNF-Myeloid-Neutrophils\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RIPK2 STEAP4 LFNG PTK2B CSF3R	2.84e-04	182	141	5	243c783675df495ea4112dbf710712c44ea6b4f1
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_2-AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NAPSA CDCP1 PRSS36 NTN4 LTA4H	2.84e-04	182	141	5	1e2149b222a3e9f64841aed45288a6f29394e7b0
ToppCell	facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_PP_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAM21 ROR2 OCRL ARHGAP6 CTHRC1	2.84e-04	182	141	5	eb4be1c02b8b033d025e57b8b4cdbfaec4698054
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ROR2 MTERF4 ATRNL1 PLXNA4 DIP2C	2.84e-04	182	141	5	ed6ae0fd8653f213fe29906a6a4e0729a62e1b75
ToppCell	LPS-IL1RA+antiTNF-Myeloid-Neutrophils-Neutrophils\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RIPK2 STEAP4 LFNG PTK2B CSF3R	2.84e-04	182	141	5	18790a394dc32b3cef99cdbf826392c520e38b4a
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-AT2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NAPSA CDCP1 PRSS36 NTN4 LTA4H	2.91e-04	183	141	5	5f2db95d44b7de68779de098892892af540fd431
ToppCell	LA-07._Pericyte\|World / Chamber and Cluster_Paper	STEAP4 DSCAML1 ARHGAP6 DLC1 IGFBP7	2.91e-04	183	141	5	e3835db4795362b0442d5893baf2a78efcc20428
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	OVCH2 ROR2 AQP3 SORCS2 ATP12A	2.91e-04	183	141	5	d340ab5a77e8d819a1dfb4ca3e9a4b9bc988923c
ToppCell	COVID-19-Epithelial_cells-AT2\|COVID-19 / group, cell type (main and fine annotations)	NAPSA ACACA STEAP4 NTN4 CSF3R	2.99e-04	184	141	5	369b82f793deab672204558ae4e112cfa5aa9ccc
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_2-AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NAPSA CDCP1 PRSS36 NTN4 LTA4H	2.99e-04	184	141	5	157a3d00165bb4a8c52c3e63ae57d9cf57500be7
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NAPSA RIPK4 PRSS36 NTN4 LTA4H	2.99e-04	184	141	5	cdf6f1c6cce97a7effa0c55959652e2c0b6992b3
ToppCell	COVID-19-Heart-Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	STEAP4 DSCAML1 ARHGAP6 DLC1 IGFBP7	2.99e-04	184	141	5	21790cdfa3b4036ad413fd44b94e31563116f25f
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-AT1-AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NAPSA RIPK4 CDCP1 PRSS36 NTN4	3.06e-04	185	141	5	3bef59cc0aa939d2a7e52f0f6c61bc00528fe50b
Computational	Response to DNA damage.	CDK20 DDX17 ABL2 ROR2 MSH5 GMPS COASY ATP12A	1.20e-04	187	86	8	MODULE_244
Drug	Cefamandole sodium salt [30034-03-8]; Up 200; 8.2uM; MCF7; HT_HG-U133A	CDK20 TNPO2 INPP5B ARHGEF11 GREB1L RIF1 CLN3 PVR FGFR4	3.07e-06	198	136	9	3436_UP
Disease	platelet component distribution width	CAPN14 C5orf67 MPDU1 RTTN DLC1 MAVS P2RY2 CLN3 PVR PREX1 PIF1	7.26e-04	755	135	11	EFO_0007984
Disease	obsolete_red blood cell distribution width	DIP2B C5orf67 ABL1 CLASP1 INPP5B TMC6 SIAH2 SCAMP2 GBA2 PRSS36 DENND4C ESYT3 BMPR2 RNF123 MAST1	1.31e-03	1347	135	15	EFO_0005192
Disease	Down syndrome (implicated_via_orthology)	DSCAML1 DOP1B	2.10e-03	15	135	2	DOID:14250 (implicated_via_orthology)
Disease	Hereditary Diffuse Gastric Cancer	DLC1 IGFBP7 CLN3 UMPS AURKB TMEM63A	2.35e-03	293	135	6	C1708349
Disease	Stomach Neoplasms	DLC1 IGFBP7 CLN3 UMPS AURKB TMEM63A	2.51e-03	297	135	6	C0038356
Disease	Malignant neoplasm of stomach	DLC1 IGFBP7 CLN3 UMPS AURKB TMEM63A	2.64e-03	300	135	6	C0024623
Disease	age at menopause	DDX17 ACACA MSH5 RIF1 BMPR2 CSF3R	2.73e-03	302	135	6	EFO_0004704
Disease	diet measurement, HOMA-B	DUSP16 PLXNA4	3.38e-03	19	135	2	EFO_0004469, EFO_0008111

Protein segments in the cluster

Peptide	Gene	Start	Entry
CIIIPIYPLLGCLIS	ABCA5	1171	Q8WWZ7
PLCQILPYADLTLEQ	ESYT3	546	A0FGR9
EQLCYVLRILGTPNP	CDK20	211	Q8IZL9
CSGPLPIEAIIYLDQ	CTHRC1	166	Q96CG8
QLLGVCTLEPPFYIV	ABL2	346	P42684
ILGLAYVAGICRPPI	ADAM21	306	Q9UKJ8
LGTPTLLAKPCYIVI	CDCP1	46	Q9H5V8
GLPLVTCALRPTGIY	HSD3B7	181	Q9H2F3
CYILPQTAPQVLRIG	GRIK1	26	P39086
LLGVCTQEGPLYVIV	FGFR4	536	P22455
LPSYLQDRCLPGVLA	BCORL1	481	Q5H9F3
ICTSKLGPPQIYELV	ARHGEF11	1046	O15085
LRECCQPVLVYIPPQ	ACACA	2071	Q13085
YIQPQPLGVVLIIGA	ALDH3A2	96	P51648
ILGIISVPLSIGYCA	DHRS7	191	Q9Y394
LIICENGYILEAPLP	CFAP44	636	Q96MT7
SLVLPIYEGIPVLNC	ACTR10	146	Q9NZ32
SQELCLEPGTYLIVP	CAPN14	461	A8MX76
LEPGTYLIVPCILEA	CAPN14	466	A8MX76
PILCQTCLGENPYIR	RBM22	21	Q9NW64
GQRILVGYPPECLDL	YOD1	86	Q5VVQ6
VPIPCYLIALVVGAL	LTA4H	196	P09960
RVDLLCTYLQPLSGP	MUC16	13991	Q8WXI7
FLCYPVPIVLISQLP	OR11H6	171	Q8NGC7
ILCAYGPVIVIYLQP	OR10D4P	246	Q8NGN7
TLTLQLPLCDPYVID	OR2B6	161	P58173
TGLPECLVPLIQLYR	PAK6	661	Q9NQU5
TLCGTPEYIAPEVLL	PSKH2	221	Q96QS6
YALIPIPLAVITTCI	CD58	216	P19256
CTIGYIVEALLGVPL	LFNG	291	Q8NES3
NVDVVEILPYLPCLT	MAVS	21	Q7Z434
PVILVNSYLICQGPL	LRIT2	221	A6NDA9
ELCPFLIYIIVGLPL	ATP12A	801	P54707
YLPQVLGCLVQPLAE	DOP1B	501	Q9Y3R5
APPYAVVLISCSGLL	LMTK3	36	Q96Q04
IYQLPTLDPLCLGDR	DCAF12L2	176	Q5VW00
ICIPSLGIILPINYT	TMEM63C	146	Q9P1W3
CTPLPGEYIIAEQIV	PLXNA2	901	O75051
CSPLVDGYIPAEQIV	PLXNA4	901	Q9HCM2
VILVIQLPFCGPNEL	OR4Q3	161	Q8NH05
TVPLVGLLVGYCLAT	SLC10A3	391	P09131
LALVVQVYCPLEGSP	PDCD2L	56	Q9BRP1
QGLIHPVQCVPYLIA	NIPBL	2311	Q6KC79
VGVYCLALVPANTLP	DIP2B	891	Q9P265
APVISVLLLSLCVPY	MARCHF6	811	O60337
LCVPYVIASGVVPLL	MARCHF6	821	O60337
YLVPACIGFPVLVAL	HM13	321	Q8TCT9
YVLEGLEIEPALCPL	NLRP5	596	P59047
VGYLINTSCLPLLQP	PLA2G4B	616	P0C869
LGCIIYQLVAGLPPF	PDPK2P	241	Q6A1A2
QVYLSCEVIGIPTPV	IGFBP7	176	Q16270
PSLQPVLFALVLLCY	OR2I1P	21	Q8NGU4
ITCPIIAPFGLIYIL	TMEM63A	626	O94886
IPRTYQDLDGLPCIV	GREB1L	1021	Q9C091
PVLAIDCYLNIGPEV	GREB1L	1811	Q9C091
LPVSYGVVCVPGLCL	P2RY2	36	P41231
QVCGTPEYIAPEVIL	MAST1	546	Q9Y2H9
LGTLQLLIYLLPPCN	ARHGAP6	501	O43182
PSPALLLLCIAYTVV	NPY6R	31	Q99463
ICDCLYQGILPPGTL	PRSS36	736	Q5K4E3
ICLEFIEPIPSYNIL	G2E3	146	Q7L622
EPPGQLLRLFYCTVL	EVA1C	26	P58658
ILLPPETYEGNLCAI	HEATR5A	676	Q86XA9
PGLAIRVICAEEPYI	GMPS	441	P49915
LVPAQPLVCLGDYRT	C5orf67	31	F2Z3F1
PSLLQYLCVQSPAGL	E2F7	701	Q96AV8
INSVPLRQIYGCPLG	GBA2	141	Q9HCG7
LCLQLYAPGLSPDTI	IFI30	161	P13284
PASIGQLLYIPCVVS	DSCAML1	606	Q8TD84
LYSGVLITLENCLLP	CCNL2	41	Q96S94
NIGPTRILPNLYLGC	DUSP16	156	Q9BY84
LANLLVILRPGPYIC	GLB1L	111	Q6UWU2
ACLIPDVLPTQIYPL	BMPR2	731	Q13873
YGCLLAEVVPVPIEV	DIP2C	401	Q9Y2E4
LIPGCEVILATPYGR	DENND4C	111	Q5VZ89
LLGVCTREPPFYIIT	ABL1	301	P00519
YAPLIAVLSGLIVPE	ATRNL1	156	Q5VV63
LVGPLPLEALQYELC	CSF3R	281	Q99062
PLEALQYELCGLLPA	CSF3R	286	Q99062
IQLLCLVSGYTPGTI	IGHE	131	P01854
LLLFLESLPEPVICY	INPP5B	886	P32019
QPYLERGDGPICLVL	DDX17	236	Q92841
YGCLLAELVPVPIEV	DIP2A	416	Q14689
NELCQLPPEGYVVVV	PTK2B	896	Q14289
VGVPVGLCYNALLVL	GPR146	36	Q96CH1
ALSGLIEIPSYPLCI	SLC22A15	341	Q8IZD6
PTLRQGCFYLLVLVP	MFSD13A	461	Q14CX5
PVLGALLVVIAGYLC	CYP8B1	6	Q9UNU6
CLVREYLLPPETQPL	ORC3	561	Q9UBD5
LLCINPPLFEIYQVL	NUP88	101	Q99567
RIPSCSVIYIPLIGF	MSH5	431	O43196
LGDSVTLPCYLQVPN	PVR	41	P15151
LCPVIPILQGYADTE	RTTN	716	Q86VV8
IQLIICGDFLQLPPV	PIF1	336	Q9H611
VLNLLVTGCVYPGIA	UTP20	1271	O75691
QRLYILLPLDCGVPD	STING1	196	Q86WV6
ILILLEPIPFYCIPT	TLR10	726	Q9BXR5
CTCPILNPGLEYLVA	NTN4	576	Q9HB63
VYPPLVNCVAPVDII	RIF1	2291	Q5UIP0
FILLGLNPEPVCVVL	MTERF4	131	Q7Z6M4
EIARLCGYDVPTPVL	OVCH2	501	Q7RTZ1
GPGQVLTYLLLPCTL	PNPLA5	336	Q7Z6Z6
SPLQALYLEVVPVIG	SORCS2	871	Q96PQ0
IPLEGYLLSPIQRIC	PREX1	186	Q8TCU6
YVLPPILQCQAGHLV	SIAH2	86	O43255
FCQIGIYIIQLVGIP	SCAMP2	226	O15127
YILVPSIAIPLVIAC	ROR2	406	Q01974
NGTITCLVLYPLIVL	SLC25A53	221	Q5H9E4
LVQAPYTVLLLPLGT	SAPCD1	11	Q5SSQ6
VNVLLSRYLIEPCGP	DLC1	1461	Q96QB1
ILPVYGICREPVGLV	RIPK4	81	P57078
CYGLVLLVLLSPLTP	MPDU1	136	O75352
LLIFLEALPEPVICY	OCRL	791	Q01968
CLAAGITYVPPLLLE	SLC45A3	31	Q96JT2
CPPDLILVLYSIGVK	STXBP5L	421	Q9Y2K9
LIVCVLAIVDPYNNP	AQP3	171	Q92482
LLPYSPRVLVSGICA	CLN3	121	Q13286
RPELPTCLYVIGLTG	COASY	351	Q13057
VLCPIIQTADYPINL	CLASP1	1426	Q7Z460
QLYLPNIPCTVIDGC	NDUFV1-DT	101	Q8NBR9
QERCPVVLAPLLYPE	CNOT1	216	A5YKK6
VRLGGETLNPVYVPC	ATG4D	306	Q86TL0
VLCYELLVGNPPFES	AURKB	261	Q96GD4
DLLSGIIPELCQKYP	PIGA	241	P37287
FLTIRLPYCGPNIID	OR4E2	161	Q8NGC2
EVEPPCIPYLGLILQ	RAPGEF1	976	Q13905
PKTLLVYVAPLCVLG	SPIDR	691	Q14159
FQLRSICYLLGQPEP	RNF123	1181	Q5XPI4
SYILPILGICNEPEF	RIPK2	76	O43353
KLVCYLGSGPVIQLL	SPOCD1	471	Q6ZMY3
AIPAITIGRLGYVCP	TNPO2	776	O14787
GQPALLYLVPCTLIT	SPPL2A	461	Q8TCT8
VCGVPYTALPLATVI	UMPS	71	P11172
PYQNIGITLVCLTIP	SLC10A6	161	Q3KNW5
LPAAYVLGLIIPCTV	STEAP4	416	Q687X5
YPGPAVVLDILAVLI	RPAP1	556	Q9BWH6
LLLLGISVCGQPVYS	PRSS48	11	Q7RTY5
CEQLYNPIGIFLPAL	PRSS48	181	Q7RTY5
PLVVGLLNLGAPYLC	TMC6	476	Q7Z403
VGITYLLPQEEQPLC	USP31	521	Q70CQ4
PALPCGVILAEYLGL	UGT1A6	151	P19224
TGQAPVVEYPICLVC	PRR30	241	Q53SZ7
IIPPVEIYSLLALCA	WDR35	1061	Q9P2L0
GVCPSVSNPLEVYLI	TRIP12	1441	Q14669
SQPYVEGLCVSLEPL	ZFC3H1	581	O60293
IPVEEALPQYVGVIC	ZNF214	191	Q9UL59
DCPIQPLIPLYLLVG	TMEM272	46	A0A1B0GTI8
GEYIILCSEIPKLPA	NAPSA	311	O96009